JP2016505551A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016505551A5 JP2016505551A5 JP2015545760A JP2015545760A JP2016505551A5 JP 2016505551 A5 JP2016505551 A5 JP 2016505551A5 JP 2015545760 A JP2015545760 A JP 2015545760A JP 2015545760 A JP2015545760 A JP 2015545760A JP 2016505551 A5 JP2016505551 A5 JP 2016505551A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- group
- heterocyclyl
- cycloalkyl
- heteroaryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12196011 | 2012-12-07 | ||
| EP12196011.6 | 2012-12-07 | ||
| PCT/EP2013/075238 WO2014086712A1 (en) | 2012-12-07 | 2013-12-02 | New indanyloxydihydrobenzofuranylacetic acids |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016505551A JP2016505551A (ja) | 2016-02-25 |
| JP2016505551A5 true JP2016505551A5 (https=) | 2017-01-19 |
| JP6283862B2 JP6283862B2 (ja) | 2018-02-28 |
Family
ID=47290800
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015545760A Expired - Fee Related JP6283862B2 (ja) | 2012-12-07 | 2013-12-02 | 新規インダニルオキシジヒドロベンゾフラニル酢酸 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20140163025A1 (https=) |
| EP (1) | EP2928886B1 (https=) |
| JP (1) | JP6283862B2 (https=) |
| AR (1) | AR093864A1 (https=) |
| TW (1) | TW201439076A (https=) |
| UY (1) | UY35171A (https=) |
| WO (1) | WO2014086712A1 (https=) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6283862B2 (ja) | 2012-12-07 | 2018-02-28 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 新規インダニルオキシジヒドロベンゾフラニル酢酸 |
| WO2015035223A1 (en) | 2013-09-09 | 2015-03-12 | Peloton Therapeutics, Inc. | Aryl ethers and uses thereof |
| IN2013MU03577A (https=) | 2013-11-14 | 2015-07-31 | Cadila Healthcare Ltd | |
| ES2737148T3 (es) | 2013-12-16 | 2020-01-10 | Peloton Therapeutics Inc | Análogos de sulfona y sulfoximina cíclicos y usos de los mismos |
| CN104177320B (zh) * | 2014-08-27 | 2016-03-02 | 广东东阳光药业有限公司 | 一种脲取代联苯类化合物及其组合物及用途 |
| WO2016145045A1 (en) | 2015-03-11 | 2016-09-15 | Peloton Therapeutics, Inc. | Compositions for use in treating glioblastoma |
| US10807948B2 (en) * | 2015-03-11 | 2020-10-20 | Peloton Therapeutics, Inc. | Aromatic compounds and uses thereof |
| US10278942B2 (en) | 2015-03-11 | 2019-05-07 | Peloton Therapeutics, Inc. | Compositions for use in treating pulmonary arterial hypertension |
| WO2016144826A1 (en) | 2015-03-11 | 2016-09-15 | Peloton Therapeutics, Inc. | Substituted pyridines and uses thereof |
| WO2016168510A1 (en) | 2015-04-17 | 2016-10-20 | Peloton Therapeutics, Inc. | Combination therapy of a hif-2-alpha inhibitor and an immunotherapeutic agent and uses thereof |
| EA035867B1 (ru) * | 2016-04-29 | 2020-08-24 | Байер Фарма Акциенгезельшафт | Синтез индазолов |
| KR102409105B1 (ko) * | 2016-04-29 | 2022-06-16 | 바이엘 파마 악티엔게젤샤프트 | 인다졸의 합성 |
| JP7050792B2 (ja) | 2017-01-26 | 2022-04-08 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | ベンジルオキシピラジニルシクロプロパンカルボン酸、その医薬組成物及び使用 |
| CN110177773B (zh) | 2017-01-26 | 2023-08-25 | 勃林格殷格翰国际有限公司 | 苄基氨基吡啶基环丙烷羧酸、其药物组合物及其用途 |
| EP3573959B1 (en) | 2017-01-26 | 2021-07-28 | Boehringer Ingelheim International GmbH | Benzylaminopyrazinylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof |
| US10913720B2 (en) | 2017-01-26 | 2021-02-09 | Boehringer Ingelheim International Gmbh | Benzyloxypyridylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof |
| US10550127B1 (en) | 2017-02-08 | 2020-02-04 | Boehringer Ingelheim International Gmbh | Indanylaminoazadihydrobenzofuranylacetic acids, pharmaceutical compositions for the treatment of diabetes |
| US11098026B2 (en) | 2017-03-13 | 2021-08-24 | Impetis Biosciences Limited | Fused bicyclic compounds, compositions and applications thereof |
| BR102018007822A2 (pt) | 2017-04-20 | 2018-11-06 | Gilead Sciences, Inc. | composto, métodos para inibir pd-1, pd-l1 e/ou interação de pd-1/pd-l1 e para tratamento de câncer, composição farmacêutica, e, kit para tratamento de ou prevenção de câncer ou uma doença ou condição |
| TWI707849B (zh) | 2018-02-13 | 2020-10-21 | 美商基利科學股份有限公司 | Pd‐1/pd‐l1抑制劑 |
| KR102591947B1 (ko) | 2018-04-19 | 2023-10-25 | 길리애드 사이언시즈, 인코포레이티드 | Pd-1/pd-l1 억제제 |
| EP3820572B1 (en) | 2018-07-13 | 2023-08-16 | Gilead Sciences, Inc. | Pd-1/pd-l1 inhibitors |
| US11236085B2 (en) | 2018-10-24 | 2022-02-01 | Gilead Sciences, Inc. | PD-1/PD-L1 inhibitors |
| JP2022552655A (ja) | 2019-10-07 | 2022-12-19 | キャリーオペ，インク． | Ｇｐｒ１１９アゴニスト |
| IL295825A (en) | 2020-02-28 | 2022-10-01 | Kallyope Inc | gpr40 agonists |
| WO2021236617A1 (en) | 2020-05-19 | 2021-11-25 | Kallyope, Inc. | Ampk activators |
| CA3183575A1 (en) | 2020-06-26 | 2021-12-30 | Iyassu Sebhat | Ampk activators |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003277576A1 (en) | 2002-11-08 | 2004-06-07 | Takeda Pharmaceutical Company Limited | Receptor function controlling agent |
| US7135575B2 (en) | 2003-03-03 | 2006-11-14 | Array Biopharma, Inc. | P38 inhibitors and methods of use thereof |
| JP4805552B2 (ja) * | 2003-05-30 | 2011-11-02 | 武田薬品工業株式会社 | 縮合環化合物 |
| EP1630152A4 (en) | 2003-05-30 | 2009-09-23 | Takeda Pharmaceutical | CONDENSED CYCLIC COMPOUND |
| US7786165B2 (en) * | 2004-03-15 | 2010-08-31 | Takeda Pharmaceutical Company Limited | Aminophenylpropanoic acid derivative |
| WO2007033002A1 (en) | 2005-09-14 | 2007-03-22 | Amgen Inc. | Conformationally constrained 3- (4-hydroxy-phenyl) - substituted-propanoic acids useful for treating metabolic disorders |
| EP2006271A4 (en) | 2006-03-30 | 2011-08-10 | Asahi Kasei Pharma Corp | SUBSTITUTED BICYCLIC CYCLIC DERIVATIVE AND USE THEREOF |
| BRPI0713378A8 (pt) * | 2006-06-27 | 2018-01-02 | Takeda Pharmaceutical | composto, pró-droga, modulador da função do receptor gpr40, agente farmacêutico uso do composto, e, método de produção de uma forma opticamente ativa de um composto |
| NZ588983A (en) | 2008-06-25 | 2011-11-25 | Daiichi Sankyo Co Ltd | Carboxylic acid compound |
| AU2009303475B2 (en) | 2008-10-15 | 2012-09-13 | Amgen Inc. | Spirocyclic GPR40 modulators |
| WO2010143733A1 (en) | 2009-06-09 | 2010-12-16 | Takeda Pharmaceutical Company Limited | Novel fused cyclic compound and use thereof |
| TW201643169A (zh) | 2010-07-09 | 2016-12-16 | 艾伯維股份有限公司 | 作為s1p調節劑的螺-哌啶衍生物 |
| AR084050A1 (es) | 2010-12-01 | 2013-04-17 | Boehringer Ingelheim Int | Acidos indaniloxidihidrobenzofuranilaceticos |
| PE20150968A1 (es) * | 2012-11-28 | 2015-07-09 | Boehringer Ingelheim Int | Nuevos acidos indaniloxi dihidrobenzofuranil aceticos |
| JP6283862B2 (ja) | 2012-12-07 | 2018-02-28 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 新規インダニルオキシジヒドロベンゾフラニル酢酸 |
-
2013
- 2013-12-02 JP JP2015545760A patent/JP6283862B2/ja not_active Expired - Fee Related
- 2013-12-02 EP EP13802010.2A patent/EP2928886B1/en not_active Not-in-force
- 2013-12-02 WO PCT/EP2013/075238 patent/WO2014086712A1/en not_active Ceased
- 2013-12-02 US US14/093,583 patent/US20140163025A1/en not_active Abandoned
- 2013-12-05 UY UY0001035171A patent/UY35171A/es unknown
- 2013-12-06 TW TW102144980A patent/TW201439076A/zh unknown
- 2013-12-06 AR ARP130104569A patent/AR093864A1/es unknown
-
2016
- 2016-04-13 US US15/097,857 patent/US9597310B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016505551A5 (https=) | ||
| US8541457B2 (en) | Aminothiazole derivatives as human stearoyl-CoA desaturase inhibitors | |
| CA2583259A1 (en) | Aromatic ring fused pyrimidine derivative | |
| RU2403258C2 (ru) | Тиазолилдигидроиндазолы | |
| JP2015511613A5 (https=) | ||
| RU2011109190A (ru) | Бензоксазолы, бензтиазолы и родственные аналоги в качестве модуляторов сиртуина | |
| RU2019123031A (ru) | (аза)индол-, бензотиофен- и бензофуран-3-сульфонамиды | |
| TW200617001A (en) | Novel glucitol derivative, its prodrug, their salt and diabetic therapeutic agent containing the same | |
| JP2013510825A5 (https=) | ||
| RU2011153772A (ru) | Фторированные аминотриазольные производные | |
| ZA200503501B (en) | Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis C viral infections and associated diseases | |
| JP2009263394A5 (https=) | ||
| RU2002131887A (ru) | Замещенные в орто-положении амиды антраниловой кислоты и их применение в качестве лекарственных средств | |
| JP2011519863A5 (https=) | ||
| JP2002523371A (ja) | ウイルス感染および関連疾患を治療または予防するための化合物、組成物および方法 | |
| JP2011521911A5 (https=) | ||
| JP2009535307A5 (https=) | ||
| JP2014532626A5 (https=) | ||
| JP2018536648A5 (https=) | ||
| JP2012519691A5 (https=) | ||
| RU2010134411A (ru) | Фенилацетамидное производное | |
| RU2008107733A (ru) | Ингибиторы gsk-3 | |
| JP2020513415A5 (https=) | ||
| RU2007124686A (ru) | Биарилоксиметилареновые карбоновые кислоты | |
| JP2015524483A5 (https=) |